You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Blood and bone marrow cancers

Blood and bone marrow cancers Products

A list of all our products on blood and bone marrow cancers

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceDiagnostics guidanceHealthTech guidanceInterventional procedures guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic prioritisation

New and updated

New and updatedNew in the last 6 months

Showing 2 products

Sort by: Date | Sort by Title

Status: In consultationRemove ‘Status: In consultation’ filter

Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma (TA306)
Status:
In consultation
Programme:
Technology appraisal guidance
Consultation end date:
9 January 2026
Published:
26 February 2014
Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphoma after 2 or more systemic treatments (review of TA677) [ID6325]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
19 January 2026
Expected publication date:
TBC